Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Clayton, B. Enderby, F. Gilchrist, J. Alexander (Stoke-on-Trent, United Kingdom). The development of an algorithm for the rational use of intravenous salbutamol in severe paediatric asthma. Eur Respir J 2008; 32: Suppl. 52, 4596

Member's Comments

No comment yet.

Related content which might interest you: The use of intravenous aminophylline in treatment of exacerbations of COPD Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD Year: 2004 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 The management of acute asthma with and without the administration of aminophylline Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Source: Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 Year: 2021 Use of parenteral long-term bronchodilators in the management of severe and life-threatening asthma Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 A new combination therapeutic approach challenging the current dogma of using inhaled corticosteroids as maintenance only to control asthma Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 The role of inhaled corticosteroids in the management of acute asthma Source: Eur Respir J 2007; 30: 1035-1037 Year: 2007 Is there a problem with inhaled corticosteroid use in COPD? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma Source: Eur Respir J 2002; 20: Suppl. 38, 8s Year: 2002 Budesonide/formoterol for maintenance and as needed — a new approach to asthma management in children Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005 Use of inhalation corticosteroids (ICS) in children with asthma in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002